pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.

Vaccines 134

Vaccines Immunization Compounding Pharmaceutical Companies 134

The People's Pharmacy

MAY 29, 2023

According to my European colleagues it is prescribed off-label for this purpose. The virus hides for decades and when the immune system is no longer able to keep it at bay the virus can cause an extremely painful skin rash that can last for weeks. When the immune system weakens, the virus can be reactivated and cause a rash.

Immunization 72

Immunization Labelling Pharmaceutical Companies Pharmaceutical Companies 72

PharmaShots

MARCH 9, 2023

In 2016, she received a special career-recognition award from Fundamed Foundation (a non-profit Spanish foundation) in the category of the most influential pharmaceutical executive from Spain over the past 15 years Education: Belén is an alumnus of the University of Alcala de Henares as an MS, Ph.D., LinkedIn Total experience: 16 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

PharmaShots

FEBRUARY 21, 2023

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. FAP-2286 (labeled with lutetium-177), a peptide-targeted radionuclide therapy (PTRT) and imaging agent targeting fibroblast activation protein (FAP), is the company’s lead asset amongst radiopharma products.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56